oxidative phosphorylation; glucose uptake DIABETES MELLITUS (DM) is a genetically heterogeneous disorder but exhibits common features of glucose intolerance and hyperglycemia (25) . It is generally considered that various genetic factors, although not all are known, cause DM. Maternally inherited mitochondrial DNA (mtDNA), which does not follow the classical Mendelian genetics, has been considered to be one of the genetic factors for developing diabetes (14) .
Approximately 0.5-1.5% of all diabetic patients exhibit pathogenic mtDNA mutations such as duplications (2), point mutations (18) , and large-scale deletions (3) . Also, diabetics show not only mutations but also quantitative changes of mtDNA. Antonetti et al. (1) reported that mtDNA copy number was ϳ50% decreased in skeletal muscles of both type 1 and type 2 diabetic patients as estimated by Southern blot analyses. Lee et al. (22) also reported that the quantitative decrease of mtDNA in lymphocytes preceded the type 2 diabetic development, suggesting that the decreased content of mtDNA might be a causal factor for type 2 diabetes. However, there is as yet no convincing evidence whether the reduction of mtDNA copy number causes enough disturbance in the glucose metabolism in peripheral tissues such as liver cells to participate in the development of diabetes.
In pancreatic ␤-cells, glucose-induced ATP production stimulates insulin secretion via mitochondrial oxidative phosphorylation. The depletion of mtDNA impairs this glucose-stimulated insulin secretion and causes glucose intolerance (16, 31) . The impairment of glucose uptake via glucose transporter in peripheral tissues may also contribute to the diabetic pathogenesis, especially of type 2 (5). For example, population studies have suggested that genetic variation in the GLUT-1 gene, an isoform of glucose transporter, is associated with an increased risk for developing type 2 diabetes (23) . To our knowledge, however, there has been no study showing that the alteration of mtDNA copy number affects glucose utilization and metabolism in peripheral tissues.
In this study, we established mtDNA-depleted ( 0 ) human hepatoma SK-Hep1 cells and investigated the effects of mtDNA depletion on glucose metabolism to test whether the decrease in mtDNA could participate in the diabetic pathogenesis. The 0 cells, established by long-term treatment with ethidium bromide (EtBr), have been important tools in investigating the function of mtDNA (21) . EtBr intercalates into circular DNA and inhibits mtDNA replication and transcription at a low concentration (0.1-2 g/ml) without any detectable effect on nuclear DNA division (16, 35) . We succeeded in isolating the 0 human hepatoma cell line, which lost the ability of oxidative phosphorylation. We observed that cellular ATP production and glucose uptake were attenuated in 0 cells. Glucose transporter expression and glucose metabolizing enzyme activities in 0 cells were also lower than in control cells. These results suggest that the decrease in mtDNA copy number may suppress glucose uptake and metabolism, which may lead to the development of glucose intolerance and diabetes.
MATERIALS AND METHODS
Cells and cell culture. Cells from the human hepatoma cell line SK-Hep1 (American Type Culture Collection, HTB-52, Rockville, MD) were grown in DMEM containing 1 mM pyruvate and supplemented with 10% fetal bovine serum (FBS), penicillin (100 IU/ml), and streptomycin (100 g/ml). They were incubated at ambient oxygen concentrations in the presence of 5% CO 2 at 37°C. The mtDNA-depleted ( 0 ) cell line was isolated by treating SK-Hep1 cells with 0.1 g/ml EtBr and 50 g/ml uridine for Ͼ10 wk in DMEM supplemented with 10% FBS. The control parental SK-Hep1 cells were maintained for the same time period in normal culture medium.
PCR and RT-PCR analyses.
To compare the mtDNA content between control and 0 SK-Hep1 cells, total cellular DNA was extracted using QIAmp Tissue Kit (Qiagen, Hilden, Germany). The PCR amplification of human mtDNA was performed in a volume of 50 l. This contained 0.25 units of Taq polymerase (Perkin-Elmer, Norwalk, CT) and 10 pmol of oligonucleotide primer pair, which was sequence specific for human mtDNA: upstream 5Ј-CCT AGG GAT AAC AGC GCA AT-3Ј and downstream 5Ј-TAG AAG AGC GAT GGT GAG AG-3Ј (630-bp product). The PCR conditions for mtDNA included an initial denaturing for 5 min and then 30 cycles as follows: denaturing for 30 s at 94°C, annealing for 30 s at 60°C, and extending for 40 s at 72°C using GeneAmp (PerkinElmer). Aliquots of the PCR reactions were analyzed by 1.1% agarose gel electrophoresis and were examined for the sizepredicted products by EtBr staining.
For quantification of mRNA expression, RT-PCR was performed. Total RNA from the cells was prepared using a modified guanidium thiocyanate-phenol-chloroform extraction method. Random hexamer-primed cDNA synthesis was performed in a final volume of 25 l containing 20 units of RNase inhibitor and 200 units of murine leukemia virus reverse transcriptase (Promega, Madison, WI) at 37°C for 60 min. Then, PCR amplification of human glucose transporter genes was performed with Taq polymerase and oligonucleotide primers. Sequence-specific primers for cytochrome c oxidase-1 (COX-1) and glucose transporters were as follows: COX-1, forward 5Ј-ACA CGA GCA TAT TTC ACC TCC G-3Ј and reverse 5Ј-GGA TTT TGG CGT AGG TTT GGT C-3Ј (336-bp product); GLUT-1, forward 5Ј-CCG CAT CAT CTG CCC ACT-3Ј and reverse 5Ј-CTG GAT GAC CGA AAA GCT A-3Ј (352-bp product); GLUT-2, forward 5Ј-CAA TGA ACC CAA AAC CAA CC-3Ј and reverse 5Ј-CAG CTG ATG AAA AGT GCC AA-3Ј (383-bp product); GLUT-3, forward 5Ј-ATC ACA GTT GCT ACA ATC GG-3Ј and reverse 5Ј-AAT TCC AAC AAC GAT GCC CA-3Ј (439-bp product); GLUT-4, forward 5Ј-ACC AAC TGG CCA TTG TTA TC-3Ј and reverse 5Ј-CGA AGA TGC TGG TCG AAT AA-3Ј (415-bp product). Amplification of the human ␤-actin gene was performed using commercial primers (Clontech, Palo Alto, CA) to enable semiquantitative normalization. In preliminary experiments, we demonstrated that the product amplification by PCR was linear at the number of cycles. As described, cycle numbers corresponding to the exponential phase of the reaction were determined to be 30 cycles for ␤-actin, COX-1, and GLUT-1, 40 cycles for GLUT-2 at 50°C annealing temperature, and 35 cycles at 58°C annealing temperature for GLUT-3 and GLUT-4. Aliquots of PCR reactions were loaded onto a 1.1% agarose gel containing EtBr, electrophoresed, visualized, and quantified by densitometry using Bioprint (Vilber Lourmat, France).
Staining of mitochondria. To study mitochondrial structure and distribution, the control and 0 SK-Hep1 cells were incubated with MitoTracker Red (Molecular Probes, Eugene, OR) for 15-45 min at 37°C and then washed three times with prewarmed phosphate-buffered saline (PBS). Cells were fixed for 10 min in 3.7% formaldehyde in PBS at pH 7.4, washed again with PBS, and then incubated with Sytox Green (Molecular Probes) for staining the nucleus. The cell preparations were visualized and photographed in a fluorescence microscope (Carl Zeiss, Jena, Germany).
Measurement of mitochondrial membrane potential. The mitochondrial membrane potential (⌬⌿ m) was measured using the fluorescent probe rhodamine 123 (Sigma Chemical, St. Louis, MO) (20) . Because rhodamine 123 is a cationic dye, it accumulates in the mitochondria driven by ⌬⌿ m. Under appropriate loading conditions, the concentration of rhodamine 123 within the mitochondria reaches sufficiently high levels that it quenches its own fluorescence. If the mitochondria depolarize, rhodamine 123 leaks out into the cytoplasm and is associated with a reduction in the amount of quenching. Thus the changes in ⌬⌿ m are revealed as changes in total fluorescence intensity (8) .
The control and 0 SK-Hep1 cells were detached from culture dishes with trypsin and washed twice with KrebsRinger Henseleit (KRH) buffer (containing in mM: 125 NaCl, 1.2 KH2PO4, 1.2 MgSO4, 6 glucose, 25 HEPES, 2 CaCl2, pH 7.4) and supplemented with 0.2% BSA. Cell suspensions (2 ϫ 10 5 cells/ml) were incubated in KRH buffer with 10 g/ml rhodamine 123 at 37°C for 10 min and washed with glucosefree KRH buffer. The measurements of ⌬⌿m were carried out in a thermostatically regulated and magnetically stirred fluorimeter cuvette (SFM-25, Bio-Tek Kontron Instruments, Milan, Italy) at a concentration of 2 ϫ 10 5 cells/ml. The changes in fluorescence intensities were measured at an excitation wavelength of 490 nm and an emission wavelength of 530 nm.
ATP assay. The cellular contents of ATP were measured using the luciferin-luciferase reaction with an ATP bioluminescence assay kit (Sigma). The harvested control and 0 SK-Hep1 cells were suspended with KRH buffer containing 0.1 mM glucose and 0.2% BSA. These cell suspensions were incubated in a 37°C shaking water bath. After addition of an assay mixture containing luciferin and luciferase, luminescence was measured immediately in a bioluminometer equipped with an injector (Lumat LB 9501, Berthold, Germany). The amounts of ATP were determined by running an internal standard, expressed as moles per milligram of protein by normalizing to the amount of cellular protein. A Bradford assay was used to determine the protein content.
Glucose uptake using 2-fluoro-
; specific activity 30 Ci/mM or 1.1 TBq/mM) was used for the uptake studies (12) . Human hepatoma SK-Hep1 cells or the established 0 cells (5 ϫ 10 5 cells/well) were cultured on a 6-well plate in DMEM until 95% confluent. The medium was changed to 1 ml of glucose-free Hanks' balanced salt solution (HBSS), and 1 Ci (37 kBq) of [ Determination of enzyme activity. COX (EC 1.9.3.1) activity was determined according to the method described by Madden and Storrie (24) . Briefly, the enzyme reaction was initiated by the addition of cell lysate to the reaction mixture, and the absorbance change at 550 nm was recorded in a spectrophotometer for a period of 1 min (Spectramax 250, Molecular Devices, Sunnyvale, CA). Succinate dehydrogenase (SDH; EC 1.3.99.1) activity was assayed by determining the absorbance change at 600 nm (28) . Lactate dehydrogenase (LDH; EC 1.1.27), glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12), glucose-6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49), and hexokinase (EC 2.7.1.1) were assayed as described (10, 17, 26, 33) . Specific activities of all enzymes were expressed as milliunits per milligram of protein, where 1 mU was defined as the amount of enzyme that catalyzes the formation of 1 nmol product/min under standard assay conditions.
Western blot analysis. Western blot analysis was performed to estimate expression level of glucose transporter in 0 cells. Total cell lysates (50 g protein) were subjected to 10% SDS-PAGE and transferred onto a nitrocellulose membrane. The membrane was incubated with goat polyclonal antibodies against human GLUT-1, -3, or -4 (1:1,000; Santa Cruz, Santa Cruz, CA) and with anti-goat IgG conjugated with horseradish peroxidase (1:1,000; Santa Cruz) after three washings in PBS. Bound antibodies were visualized with an enhanced chemiluminescence system (Amersham, Buckinghamshire, England). The antibody against ␤-actin was utilized to confirm the equal loading of the sample. Statistical analysis. Data shown are expressed as means Ϯ SE. Statistical significance was evaluated by paired or unpaired Student's t-test, and P Ͻ 0.05 was considered significant.
RESULTS

Establishment of
0 SK-Hep1 cells. To establish the mtDNA-depleted cells, the SK-Hep1 human hepatoma cells were treated with the medium containing 0.1 g/ml EtBr and 50 g/ml uridine for 10 wk, and the mtDNA contents of the EtBr-treated cells were examined by PCR. Figure 1A shows that mtDNA was not amplified from genomic DNAs of EtBr-treated cells, which are different from the control cells. On the other hand, the ␤-actin gene, a nuclear DNA control, was amplified in both control and EtBr-treated cells. This observation demonstrated that the EtBr-treated SKHep1 cells were entirely devoid of mtDNA ( 0 cells). We stained the 0 or control SK-Hep1 cells with MitoTracker, a mitochondrial membrane potential-dependent fluorescent dye, to visualize the mitochondrial structure. As shown in Fig. 1B , 0 cells lost the reticulum structure of mitochondria in cytoplasm compared with the control SK-Hep1 cells, suggesting that they might lose a functional structure of mitochondria.
Loss of ⌬⌿ m in 0 cells. To confirm whether 0 cells lost oxidative phosphorylation activity, we measured ⌬⌿ m using rhodamine 123. In control SK-Hep1 cells, an application of 10 mM glucose hyperpolarized ⌬⌿ m , and the subsequent treatment with carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP; 1 M), a mitochondrial uncoupler, rapidly depolarized ⌬⌿ m (n ϭ 10). However, the 0 cells did not hyperpolarize ⌬⌿ m upon glucose application, indicating that the 0 cells may be unable to utilize glucose metabolites as substrates for ATP production through the tricarboxylic acid cycle. Furthermore, the 0 cells failed to change ⌬⌿ m when treated with FCCP alone, which reflected the amplitude of resting ⌬⌿ m (n ϭ 6; Fig. 2A ). Figure  2B shows the quantitative changes of ⌬⌿ m in the control or 0 cells by either glucose or FCCP. This result suggests that the 0 cells lack the basal proton gradient across the mitochondrial membrane as well as the glucose-stimulated gradient generation.
Decreased COX activity in 0 cells. The three subunits of COX complex (COX-1, -2, and -3) in the mitochondrial electron transfer system are encoded by mtDNA, whereas the other 10 subunits are encoded by nuclear DNA. We determined the steady-state mRNA levels of COX-1 in the control and 0 cells by RT-PCR. As expected, the COX-1 mRNA was nearly absent, whereas ␤-actin was normally expressed in 0 cells (Fig. 3) . The total cellular enzyme activity of COX was found to be significantly decreased in 0 cells compared with that in the control cells (2.4 Ϯ 0.6 vs. 1.0 Ϯ 0.7 mU/mg protein; n ϭ 4, P Ͻ 0.01). In contrast, the specific activity of SDH, of which all subunits are nuclear DNA encoded, were slightly increased by mtDNA depletion (353 Ϯ 15 vs. 400 Ϯ 28 mU/mg protein; n ϭ 5, P Ͻ 0.05).
Attenuated ATP production in 0 cells. There are several reports showing that the adipocytes and muscle cells initially decrease the intracellular ATP content by inhibiting oxidative phosphorylation but subsequently recovering it (4). Results from mtDNA depletion were different from this. In the case of (Fig. 4) . Reduced glucose uptake and glucose transporter expression in 0 cells. To investigate whether mtDNA depletion impairs glucose utilization, glucose uptake was assessed using [ 3 H]FDG, a radiolabeled, nondegradable glucose (12) . The resting and insulin-stimulated [ 3 H]FDG uptakes in 0 cells were decreased by ϳ30% compared with the control cells (Fig. 5) .
It is possible that the decrease in glucose uptake may result from an alteration of glucose transporter expressions. The steady-state levels of mRNA and proteins of the glucose transporter isoforms, GLUT-1, -2, -3, and (Fig. 6) . However, the mRNA of GLUT-2 was not present in either control or 0 SK-Hep1 cells (data not shown). To a similar degree, the protein levels of GLUT-1, GLUT-3, and GLUT-4 were attenuated in 0 cells (Fig. 7 ). These data demonstrate that the mtDNA depletion downregulated the expression of glucose transporters, which were nuclear encoded, resulting in a reduction of glucose utilization.
Activities of glucose-metabolizing enzymes. The effects of mtDNA depletion on glycolysis and pentose phosphate shunt were determined by cellular activities of GAPDH and G6PDH. The specific activities of GAPDH and G6PDH in 0 cells were reduced to 75 and 30% of the control cells, respectively (Table 1) . Interestingly, the activity of hexokinase in 0 cells was only 10% of the control cells. The activity of LDH, an indicator for the intracellular NADH accumulation due to dysfunction of the respiratory chain, was 53% enhanced in 0 cells. The increased LDH activity in 0 cells implies that the minimal energy production for cell survival might be achieved via anaerobic metabolism.
DISCUSSION
Mitochondria are intracellular organelles that are the site of oxidative phosphorylation and the primary source of cellular energy (34) . It is known that mutations, deletions, and insertions of mtDNA result in mitochondrial dysfunction associated with the pathogenesis of various mitochondrial diseases, including DM (3). There are also several lines of evidence to support the idea that the alterations of mtDNA quantity may cause mitochondrial diseases. First, depletions of mtDNA in muscle, liver, and kidney were reported in fatal mitochondrial encephalopathies (27) . Second, streptozotocin, one of the diabetogenic agents, reduced the levels of mtDNA content and its transcripts in pancreatic islets (11) . Third, ␤-cells of adult Goto-Kakizaki rats, a genetic model of defective insulin secretion and hyperglycemia, had a significantly smaller mitochondrial volume compared with the ␤-cells of control rats (29) . Fourth, mtDNA depletion inhibited glucose-stimulated increases of the intracellular free Ca 2ϩ concentration and insulin secretion in mouse insulinoma cells, which led to glucose intolerance and hyperglycemia (31) . Finally, in our laboratory, the decrease of mtDNA content preceded the development of diabetes (22) , suggesting that the quantitative reduction of mtDNA be considered as one Fig. 3 . Steady-state mRNA levels of cytochrome c oxidase (COX)-1. Total RNAs were isolated from SK-Hep1 and 0 SK-Hep1 cells, and the mRNA levels of COX-1 and ␤-actin were determined by RT-PCR, as described in MATERIALS AND METHODS. The products were visualized on agarose gel after EtBr staining. Fig. 4 . Intracellular ATP contents at basal state and after glucose stimulation (10 mM; arrows) were compared between SK-Hep1 (F, n ϭ 13) and its 0 cells (E, n ϭ 11), which were measured by bioluminometer using luciferin-luciferase reaction. ATP contents were normalized to cellular protein and expressed as nanomoles per milligram of cellular protein. Data are expressed as means Ϯ SE. In this study, we established the mtDNA-depleted 0 cells using SK-Hep1, a rapidly proliferating human hepatoma cell, to study whether decreased mtDNA might disturb the glucose metabolism in liver cells, resulting in diabetes. First, the 0 SK-Hep1 cells showed a slower growth rate than the parental SKHep1 cells, which was similar to the case of 0 HeLa cells (7) . Because of the low levels of intracellular ATP content and G6PDH, which are determinants of NADPH production and are essential for cell growth, it may be natural for 0 cells to grow slowly (32) . However, growth retardation was not observed in all mtDNA-depleted cells; the growth rate of human 0 osteosarcoma cells was normal (21) . This finding indicates that different cells exhibit different sensitivities to intracellular changes elicited by mtDNA depletion. Defects in glucose uptake into muscles and adipose tissues are generally accepted as one of the major characteristics of type 2 DM. A decrease in hepatic glucose uptake was also reported in type 2 diabetic patients and animal models (5, 30 ). The basal [
3 H]FDG uptake into 0 cells was decreased by 30% compared with the control cells, whereas insulin-stimulated uptake did not occur in either 0 or control cells. Because GLUT-4 is known to play a major role in insulinresponsive glucose transport in peripheral tissues, including muscles and adipose tissues, GLUT-4 might contribute to total glucose uptake relatively less than others (19) in SK-Hep1 cells. This is consistent with the fact that GLUT-3 and GLUT-4 are expressed at a relatively lower level in SK-Hep1 cells than GLUT-1. GLUT-1, which is dominant in fetal hepatocytes (15) , is the most abundant type of glucose transporter in SKHep1 cells. We found that the mRNA of GLUT-2, a Fig. 6 . Steady-state mRNA levels of glucose transporters. Total RNA was isolated from SK-Hep1 or its 0 cells. The steady-state mRNA levels of GLUT-1 (n ϭ 9), GLUT-3 (n ϭ 5), GLUT-4 (n ϭ 4), and ␤-actin were determined by RT-PCR. A: representative pictures are shown. GLUT-2 was not expressed in either group of cells. B: band intensities of the transporters were normalized to the intensity of ␤-actin and expressed as the ratio (GLUT/␤-actin). Data are means Ϯ SE; *P Ͻ 0.05, **P Ͻ 0.01. Fig. 7 . Protein expression levels of glucose transporters. Total cell lysates (50 g protein) were subjected to 10% SDS-PAGE. Western blot analysis was performed using goat polyclonal antibody against human glucose transporters (GLUT-1, -3, and -4) . Bound antibodies were visualized with enhanced chemiluminescence. The antibody against human ␤-actin was utilized to confirm the equal loading of the samples. major glucose transporter in normal adult hepatocytes, was not detected in control SK-Hep1 cells, as it has been reported that the expression of GLUT-2 was severely decreased throughout hepatocarcinogenesis (15) . Also, depletion of mtDNA significantly attenuated the expression of all types of glucose transporters that are encoded by nuclear DNA. Further studies are needed to show how alterations of mtDNA could affect the expression of nuclear DNA-encoded proteins involved in glucose transport but not a structural protein like ␤-actin.
It is possible that the decreased glucose uptake reduces the glucose supply for enzymes involved in glucose metabolic pathways. These enzymes may be inactivated or downregulated. As expected, we found that, in 0 cells, the activities of hexokinase, GAPDH, and G6PDH were decreased by 90, 25, and 70%, respectively. These data suggest that the depletion of mtDNA decreased glucose utilization by suppressing glucose metabolism in addition to reducing glucose uptake. Furthermore, the attenuated activities of glycolytic enzymes could consequently reduce ATP production, which may aggravate ATP depletion in 0 cells in a vicious cycle.
It is interesting to note the large decrease of hexokinase activity in 0 cells. In contrast to other glycolytic enzymes, hexokinase is known to be associated with the mitochondrial outer membrane through its interaction with porin and uses intramitochondrial ATP supplied by oxidative phosphorylation as a substrate for glucose phosphorylation (9) . Moreover, the activation of hexokinase depends on a contact site-specific structure of the pore, which is voltage dependent and influenced by the electrical potential of the mitochondrial inner membrane (13) . It has been reported that mitochondria lacking a membrane potential induced by a mitochondrial uncoupler such as dinitrophenol decreases the contacts and hexokinase activity in hepatocytes (6) . We also observed that the hexokinase protein was significantly decreased in mitochondrial fraction from 0 cells, and this was determined by Western blotting assay (unpublished data). Therefore, we can infer that the defects in intramitochondrial ATP production and depolarized ⌬⌿ m in 0 cells could inactivate hexokinase. Furthermore, the decreased hexokinase activity in 0 cells may be one of the fundamental causes of the disturbed glucose metabolism.
This study demonstrates for the first time that mtDNA depletion may disturb the cellular capacity for glucose utilization, at least in liver cells, although the study was performed in a single cell line and not over a wide variety of cell types. Further studies on other changes in various types of mtDNA-depleted cell lines would be helpful in extending our knowledge about the pathogenic role of quantitative changes in mtDNA.
